Marker Therapeutics Inc (MRKR)

[Phantom Lord]

Obviously they can't tell you when they plan on doing the call since they haven't sent out the press release. They basically confirmed that it is going to happen so It isn't a huge deal at this point, IMO.

I spoke to IR regarding it as well and from what it sounds like it's going to be more of just a company update rather than a focus on the Q3 results. Which is good because honestly at this point that's not what people are after. They want to hear about what the future plans are, again, IMO. I'm mostly concerned, aside from knowing what their plans are moving forward, with them addressing their failure to PR the data from the TPIV200/Durvalumab combo trial. They essentially wait two months and then just stick it in the 10Q and don't even acknowledge the trial won't be continuing. They even direct you to clinicaltrials.gov for updates knowing damn well there are no more updates to come.

Like I said before I'm giving them the benefit of the doubt since clearly the company is positioned well for future growth but they better not screw this call up.